A stomach bacterium best known for causing ulcers may also be quietly driving one of the world's fastest-growing liver conditions, and a sweeping new study puts hard numbers on the risk.
What if your gut bacteria could quietly siphon off 116 calories a day before your body ever absorbs them? A tightly controlled clinical trial just measured exactly that.
Fecal transplants work, but they come with real drawbacks: donor variability, pathogen risk, and no easy way to scale. A new Mount Sinai trial suggests a precisely engineered 15-strain bacterial therapy could change that.
Your gut bacteria don't just digest food; they also reactivate sex hormones that tell your intestines how fast to move. A new study in Nature Neuroscience reveals the precise enzymatic mechanism behind this surprising circuit.
A new genetic study has traced a causal path from specific gut microbes to liver cancer, using chromosomal inheritance patterns to cut through the noise of diet, lifestyle, and reverse causation.
Two bacteria acquired in the first year of life appear to dampen the risk of autism and ADHD in babies already predisposed by their epigenetic profile at birth. A new study from nearly 1,000 families suggests that conversation between genes and gut may start at the moment of delivery.
A bacterium that normally lives in your mouth has been caught colonizing tumors across six cancer types, rewriting immune signals and accelerating metastasis in ways that could reshape how oncologists think about treatment resistance.
Most microbiome tests tell you who's living in your gut, not what they're actually doing. A new oral tyrosine challenge test aims to change that by measuring the metabolic output of gut bacteria in real time.
Eating at irregular times does more than disrupt your schedule. A large Korean study found it raises the odds of depression by 55%, with breakfast skipping and monotonous diets compounding the harm considerably.
A disrupted gut microbiome does more than upset digestion. New research shows it can flood the body with bile acids that actively push hormone receptor-positive breast tumors to spread.